Coya Therapeutics raises $11.1M via private placement with Dr. Reddy's and Greenlight Capital

Coya Therapeutics, Inc.

Gross proceeds of ~$11.1M from sale of 2,522,727 shares at $4.40 each; no broker/agent.
Dr. Reddy's Labs invests $10M, Greenlight Capital $1.1M; expected close Jan 30, 2026.
Proceeds to accelerate tech transfer and scale-up manufacturing for low dose IL-2 to support COYA 302.
Reiterates cash runway into H2 2027 and past projected ALSTARS trial topline.

item 1.01 item 3.02 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Coya Therapeutics, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at approximately $11.1 million (effective 2026-01-29).

Action: entry
Agreement: equity purchase
Counterparty: certain accredited investors
Value: approximately $11.1 million
Effective: 2026-01-29

Exact text from the filing

On January 29, 2026, Coya Therapeutics, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Securities Purchase Agreement ”) with certain accredited investors

View on SEC.gov

284 material agreements filed in the last 30 days. Browse all material agreements →

Coya Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-030531

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.